http://web.pac-ci.org/fr/d%C3%A9tails-projet/a-sthreet-039-grant-39c7a62025-10-23weekly0.7http://web.pac-ci.org/en/project-details/a-sthreet-039-grant-39c7a62025-10-23weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/ado-pas-anrs0343-7789992026-10-05weekly0.7http://web.pac-ci.org/en/project-details/teenager-not-anrs0343-7789992026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/adultes-en-echec-de-seconde-ligne-de-traitement-ar2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/adults-who-have-failed-second-line-treatment-ar2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/adultes-vih-a-date-de-seroconversion-connue2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/adults-with-hiv-and-a-known-date-of-seroconversion2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/project-3bd7272025-11-25weekly0.7http://web.pac-ci.org/en/project-details/project-3bd7272025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/aima-cc-4f89cd2025-11-25weekly0.7http://web.pac-ci.org/en/project-details/aima-cc-4f89cd2025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/aire-b01e922025-11-25weekly0.7http://web.pac-ci.org/en/project-details/area-b01e922025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/alerrt-fissa-7db4592025-11-25weekly0.7http://web.pac-ci.org/en/project-details/alerrt-fissa-7db4592025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/alpe-tbm2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/alpe-tbm2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/amelioration-de-la-qualite-des-services-communauta2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/improving-the-quality-of-community-services2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/ayani-58917f2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/ayani-58917f2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/combinepmc2026-11-06weekly0.7http://web.pac-ci.org/en/project-details/combinepmc2026-11-06weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/consequences-du-stade-de-debut-de-traitement-arv-s2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/consequences-of-the-early-stage-of-antiretroviral-2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/consequences-sociales-des-traitements-arv-precoces2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/social-consequences-of-early-antiretroviral-treatm2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/covadoci-e6f4702025-11-25weekly0.7http://web.pac-ci.org/en/project-details/covadoci-e6f4702025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/coverage-africa-2fbb652025-11-25weekly0.7http://web.pac-ci.org/en/project-details/coverage-africa-2fbb652025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/covicompare-guinee-1232e82025-11-25weekly0.7http://web.pac-ci.org/en/project-details/covicompare-guinea-1232e82025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/daisy-9e9b0a2025-11-25weekly0.7http://web.pac-ci.org/en/project-details/daisy-9e9b0a2025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/debut-precoce-du-traitement-antiretroviral2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/early-initiation-of-antiretroviral-therapy2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/decide-tb-9e9ccb2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/decide-tb-9e9ccb2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/diagnostic-moleculaire-de-la-mono-infection-vih-22026-04-02weekly0.7http://web.pac-ci.org/en/project-details/molecular-diagnosis-of-hiv-2-monoinfections2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/difficultes-psycho-sociales-des-adolescents-infect2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/psychosocial-difficulties-among-adolescents-with-h2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/dod-ci-demande-et-offre-de-depistage-du-vih-et-de2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/dod-ci-requests-and-offers-hiv-testing-and2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/doreal2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/doreal2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/ebo-pep-3293e72026-11-06weekly0.7http://web.pac-ci.org/en/project-details/ebo-pep-3293e72026-11-06weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/echec-virologique-et-resistances-chez-1000-adultes2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/virological-failure-and-resistance-in-1000-adults2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/ehealth4childtb-626bd52026-10-05weekly0.7http://web.pac-ci.org/en/project-details/ehealth4childtb-626bd52026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/eldorado-cd24932026-10-05weekly0.7http://web.pac-ci.org/en/project-details/eldorado-cd24932026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/ediimark-2-931dd42025-10-23weekly0.7http://web.pac-ci.org/en/project-details/ediimark-2-931dd42025-10-23weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/ediimark-2-d30ad12025-12-24weekly0.7http://web.pac-ci.org/en/project-details/ediimark-2-d30ad12025-12-24weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/essai-de-phase-iii-randomise-sans-insu-multicent2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/a-randomized-open-label-multicenter-phase-iii-tria2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/essai-randomise-non-comparatif-de-phase-iib-san2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/phase-iib-non-comparative-randomized-trial-san2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/etude-ancillaire-i-f8e5b72025-11-25weekly0.7http://web.pac-ci.org/en/project-details/supplementary-study-i-f8e5b72025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/tb-maca-eca65f2025-10-23weekly0.7http://web.pac-ci.org/en/project-details/tb-maca-eca65f2025-10-23weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/evaluation-de-la-prise-en-charge-du-vih-en-afrique2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/assessment-of-hiv-care-in-africa2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/evolcov-51bf222025-11-25weekly0.7http://web.pac-ci.org/en/project-details/evolcov-51bf222025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/evolution-et-valeur-pronostique-du-test-quantifero2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/development-and-predictive-value-of-the-quantifero2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/faisabilite-tolerance-et-efficacite-dun-traiteme2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/feasibility-tolerability-and-efficacy-of-a-treatme2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/fozivudine-in-africa-trials-initiative-fati2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/fozivudine-in-africa-trials-initiative-fati2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/fragericare-fd50b02026-10-05weekly0.7http://web.pac-ci.org/en/project-details/fragericare-fd50b02026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/french-tb-9ba57c2025-10-23weekly0.7http://web.pac-ci.org/en/project-details/french-tb-9ba57c2025-10-23weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/gericare2026-01-22weekly0.7http://web.pac-ci.org/en/project-details/gericare2026-01-22weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/gestion-des-etudes-cliniques-en-afrique2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/clinical-trial-management-in-africa2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/gouvernance-et-sida-en-afrique-comprendre-et-ren2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/governance-and-aids-in-africa-understanding-and-ad2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/hipocamp2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/hippocampus2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/ic-sari-f96a9c2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/ic-sari-f96a9c2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/imova-9b561c2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/imova-9b561c2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/indicateur-de-qualite-des-essais-therapeutiques-su2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/quality-indicator-for-clinical-trials-su2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/integrate-77ef262026-10-05weekly0.7http://web.pac-ci.org/en/project-details/integrate-77ef262026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/intense-tbm-0094a32026-10-05weekly0.7http://web.pac-ci.org/en/project-details/intense-tbm-0094a32026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/iphother2026-01-22weekly0.7http://web.pac-ci.org/en/project-details/iphother2026-01-22weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/ipora-7651cc2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/ipora-7651cc2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/lascope2026-01-22weekly0.7http://web.pac-ci.org/en/project-details/lascope2026-01-22weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/1000-jours-a10a042025-10-23weekly0.7http://web.pac-ci.org/en/project-details/1000-days-a10a042025-10-23weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/les-1000-premiers-jours-de-lenfant-nigerien-eff2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/the-first-1000-days-of-a-nigerian-childs-life-eff2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/les-dynamiques-de-mobilisations-collectives-en-mil2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/the-dynamics-of-collective-mobilization-in-mil2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/lilac-tb-266e8c2026-01-22weekly0.7http://web.pac-ci.org/en/project-details/lilac-tb-266e8c2026-01-22weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/lymphobv-7bd0d82025-10-23weekly0.7http://web.pac-ci.org/en/project-details/lymphobv-7bd0d82025-10-23weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/lymphomes-non-hodgkiniens-en-afrique-de-louest2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/non-hodgkins-lymphomas-in-west-africa2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/depistneo-9c03372026-01-22weekly0.7http://web.pac-ci.org/en/project-details/depistneo-9c03372026-01-22weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/moderato2025-11-25weekly0.7http://web.pac-ci.org/en/project-details/moderato2025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/nutrivax-malaria2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/nutrivax-malaria2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/nutrivax-measles-nigeria2025-11-25weekly0.7http://web.pac-ci.org/en/project-details/nutrivax-measles-nigeria2025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/obstacles-au-depistage-du-vih-en-milieu-de-soin-en2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/barriers-to-hiv-screening-in-healthcare-settings-i2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/optimise-ao2025-11-25weekly0.7http://web.pac-ci.org/en/project-details/optimizes-ao2025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/optitri-string-0dbb352026-10-05weekly0.7http://web.pac-ci.org/en/project-details/optitri-string-0dbb352026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/poa-pragmatic-use-of-long-acting-oral-art-in-afri2026-10-05weekly0.7http://web.pac-ci.org/en/project-details/pragmatic-use-of-long-acting-oral-contraceptives-i2026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/prevention-de-linfection-par-le-vih-chez-les-hsh-22026-04-02weekly0.7http://web.pac-ci.org/en/project-details/prevention-of-hiv-infection-among-men-who-have-s-22026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/prevention-de-linfection-par-le-vih-chez-les-hsh2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/prevention-of-hiv-infection-among-men-who-have-sex2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/anrs-12381-princesse-77ea052026-01-22weekly0.7http://web.pac-ci.org/en/project-details/anrs-12381-princess-77ea052026-01-22weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/prise-en-charge-standardisee-de-la-cryptococcose2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/standardized-management-of-cryptococcosis2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/proxisante2025-11-25weekly0.7http://web.pac-ci.org/en/project-details/proxisant2025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/radar2025-11-25weekly0.7http://web.pac-ci.org/en/project-details/radar2025-11-25weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/representation-des-essais-therapeutiques-par-les-p2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/representation-of-clinical-trials-by-p2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/resistance-aux-arv-chez-les-patients-sous-traiteme2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/arv-resistance-in-patients-undergoing-treatment2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/resistance-du-vhb-sans-arv-sous-monotherapie-par2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/vhb-resistance-without-arvs-during-monotherapy-wit2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/revive-23f0682026-10-05weekly0.7http://web.pac-ci.org/en/project-details/revive-23f0682026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/simplification-du-traitement-arv-pediatrique-en-un2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/streamlining-pediatric-arv-treatment-into-a-single2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/srn-a555612025-10-31weekly0.7http://web.pac-ci.org/en/project-details/srn-a555612025-10-31weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/tb-srn-4c29612026-01-22weekly0.7http://web.pac-ci.org/en/project-details/tb-srn-4c29612026-01-22weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/timpani-481aa42026-10-05weekly0.7http://web.pac-ci.org/en/project-details/timpani-481aa42026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/traitement-antituberculeux-systematique-empirique2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/systematic-empirical-antituberculosis-treatment2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/medhar-be612f2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/medhar-be612f2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/utcma2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/utcma2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/vaccin-pathogenicite-vih2026-04-02weekly0.7http://web.pac-ci.org/en/project-details/hiv-vaccine-pathogenicity2026-04-02weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/virage-af2b642026-10-05weekly0.7http://web.pac-ci.org/en/project-details/virage-af2b642026-10-05weekly0.7http://web.pac-ci.org/fr/d%C3%A9tails-projet/wakobo-ti-kodro2026-01-22weekly0.7http://web.pac-ci.org/en/project-details/wakobo-ti-kodro2026-01-22weekly0.7